Etsimo is an AI-assisted mobile diagnostic search tool as a starting point for self-assessing one's condition to determine care needs and next steps. It works on top of any document collection, refining existing indexes and keywords, thus extracting more value from available information without messing with the current monetization schemes.
Missing: Etsimo's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Etsimo's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Etsimo
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Etsimo is included in 4 Expert Collections, including Artificial Intelligence.
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Latest Etsimo News
Mar 2, 2021
Finnish healthtech Etsimo expands in Latin America Finnish healthtech Etsimo, which uses AI and machine learning on top of health data to offer predictive and preventative solution to healthcare providers and insurance companies said it has agreed on co-operation with Peruvian telemedicine provider Lolimsa. Etsimo will initially provide its ‘diagnosis and triage’ platform to Lolimsa’s patients in Peru with further ‘platform services’ roll out across other regions planned for third quarter of 2021. “To expand our service, we needed a first-grade diagnosis and triage platform. We believe Etsimo can support our medical staff and patients with remote care, to increase the access to care and to lower the overall cost of care,” said Rolando Liendo, Chief Executive of Lolimsa. Lolimsa is a Latin American company that is specialised in healthcare software. Its software is used in more than 230 hospitals, clinics, medical centres in 12 different countries. “With this agreement, we were able to build on our experience in Brazil and to expand our offering to the countries where it matters most,” said Thomas Grandell, CEO Etsimo. “We now have a truly global solution that fits current and future needs of care institutions, and we can leverage this experience to provide better solutions for all our clients moving forward, where digital health will transform from curative to predictive, to truly deliver preventive, personal care,” he said.
Etsimo Frequently Asked Questions (FAQ)
When was Etsimo founded?
Etsimo was founded in 2016.
Where is Etsimo's headquarters?
Etsimo's headquarters is located at Itäinen Rantakatu 74D 172, Turku.
What is Etsimo's latest funding round?
Etsimo's latest funding round is Corporate Minority.
Who are the investors of Etsimo?
Investors of Etsimo include Terveystalo and Vertical Accelerator.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.